Resonance Health develops unique quantitative MRI image analysis technologies for the diagnosis and monitoring of human disease which are delivered to the market through our imaging core laboratory facility. A quality, controlled standardised approach to image capture and analysis is key to achieving accurate and reproducible results in the field of quantitative image analysis.

FerriScan^® is a non-invasive imaging alternative to liver biopsy for accurately quantifying liver iron, and has gained regulatory approval by the FDA and other key regulatory agencies. FerriScan is delivered to both the clinical and research communities through our imaging core laboratory facility providing quality assured and standardised data acquisition and image analysis procedures.

To access the clinical presentation for FerriScan, please click Transfusional or Hereditary Haemochromatosis

Resonance Health continues to progress key research activities into the development of MRI markers and analysis technology for the early detection of liver fibrosis. Click here for details of our active clinical studies.

Imaging Core Laboratory Services have been provided by Resonance Health for over 5 years to large pharmaceutical clients involved in multicentre global clinical trials. Resonance Health provides a range of services from protocol design, site identification, setup and initiation, training, quantitative digital image analysis, project management, data management and reporting.

Our ISO 9001:2008 certified facility is dedicated to providing a high level of quality control and assurance across all aspects of the service. Our web based infrastructure allows the secure and convenient transmission of data, job tracking and immediate access to results.